Pacific Center for Emerging Infectious Diseases Research

太平洋新发传染病研究中心

• 批准号: 9098820
• 负责人: RICHARD YANAGIHARA
• 金额: $ 115.5万
• 依托单位: UNIVERSITY OF HAWAII AT MANOA
• 依托单位国家: 美国
• 财政年份: 2015
• 资助国家: 美国
• 起止时间: 2015-07-01 至 2020-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9098820
• 关键词: Accounting; Affect; Animals; Area; Asia; Avian Influenza; Award; Basic Science; Bioinformatics; Biological Sciences; Biomedical Research; Businesses; Cellular Immunology; Center for Translational Science Activities; Centers of Research Excellence; China; Clinical Research; Collaborations; Communicable Diseases; Communities; Data; Development; Diagnostic; Diagnostic tests; Ebola virus; Economics; Emerging Communicable Diseases; Ensure; Epidemic; Epigenetic Process; Extramural Activities; Faculty; Fostering; Foundations; Funding; Future Generations; Genetic; Goals; Grant; Growth; Guinea; Hawaii; Hawaiian population; Health; Health Services Research; Human; Infectious Diseases Research; Institution; International; Investments; Liberia; Mentors; Microbiology; Middle East Respiratory Syndrome Coronavirus; Mission; Modeling; Molecular Immunology; Monitor; Movement; National Institute of General Medical Sciences; Nutritional; Pacific Island Americans; Pakistan; Parasites; Phase; Poliomyelitis; Population Growth; Positioning Attribute; Prevention; Preventive Medicine; Principal Investigator; Productivity; Public Health; Recruitment Activity; Research; Research Infrastructure; Research Personnel; Research Priority; Resource Sharing; Resources; Science; Scientist; Sierra Leone; Speed; Stream; System; Therapeutic; Training; Training Support; Training and Education; Translational Research; Triad Acrylic Resin; Tropical Medicine; United States National Institutes of Health; Universities; Urbanization; Vaccines; base; biobehavior; disease diagnosis; ethnic disadvantage; ethnic minority population; graduate student; higher education; improved; microbial; next generation; novel vaccines; operation; programs; public health relevance; research and development; social

 DESCRIPTION (provided by applicant): Established in 2003, the Pacific Center for Emerging Infectious Diseases Research, a translational science center of excellence supported by funding from the Centers of Biomedical Research Excellence (COBRE) component of the Institutional Development Award (IDeA) program, seeks to develop and deploy rapid diagnostics, improved therapeutics and affordable vaccines for new, emerging and re-emerging infectious diseases that disproportionately affect underserved communities in the Asia-Pacific region. The COBRE Center also seeks to increase the diversity of the biomedical research workforce by training and mentoring native Hawaiians and other underrepresented Pacific Islanders. Thus, the Center's mission is thoroughly consistent with that of the National Institute of General Medical Sciences, which is to support basic research that lays the foundation for advances in disease diagnosis, treatment and prevention, and to increase the diversity of the research workforce by supporting the training of the next generation of scientists (http://www.nigms.nih.gov/About/Pages/default.aspx). The principal objective of the Phase III COBRE for emerging infectious diseases is to enhance the conditions that accelerate the pace of scientific discovery, heighten research productivity and increase competitiveness for extramural funding. The objective will be achieved by (1) enhancing the growth and sustainability of the COBRE cores in biocontainment, bioinformatics, and molecular and cellular immunology, which are grounded in the triad of customized and collaborative service, research and development, and education and training; and (2) developing and implementing a COBRE Small Grants Program, without borders, that fosters collaborations and partnerships, promotes data and resource sharing, and provides additional opportunities for mentoring and specialized training across IDeA-funded centers in research aimed at improving human health. COBRE funding during Phases I and II has transformed the landscape for mentoring and training future generations of investigators and has provided state-of-the-art core resources for multi-disciplinary collaborative research on epidemic infectious diseases. At the institutional level, COBRE funding has spurred significant commitments to recruit and retain a new cadre of productive faculty, and such efforts will continue into Phase III. High-level upper-administrative institutional commitments will ensure the sustainability of the Center and its cores beyond the Phase III COBRE period.

 描述（申请人提供）：太平洋新兴传染病研究中心成立于2003年，是一个卓越的转化科学中心，由机构发展奖（IDEA）计划的生物医学研究卓越中心（COBRE）组成部分提供资金支持，旨在开发和部署快速诊断，改进治疗方法和负担得起的疫苗，新出现和重新出现的传染病对亚太区域得不到充分服务的社区的影响尤为严重。COBRE中心还寻求通过培训和指导夏威夷本地人和其他代表性不足的太平洋岛民来增加生物医学研究人员的多样性。因此，该中心的使命与国家普通医学研究所的使命完全一致，即支持为疾病诊断、治疗和预防方面的进步奠定基础的基础研究，并通过支持下一代科学家的培训来增加研究队伍的多样性（http：//www.nigms.nih.gov/About/Pages/default.aspx）。针对新发传染病的COBRE第三阶段的主要目标是改善条件，加快科学发现的步伐，提高研究生产力，并提高校外资金的竞争力。这一目标将通过以下方式实现：（1）加强COBRE在生物防护、生物信息学以及分子和细胞免疫学方面核心的增长和可持续性，这些核心以定制和协作服务、研究与开发以及教育和培训三位一体为基础;以及（2）制定和实施COBRE小额赠款计划，无国界，促进合作和伙伴关系，促进数据和资源共享，并提供额外的机会，为指导和专业培训，在整个IDEA资助的中心，旨在改善人类健康的研究。COBRE在第一和第二阶段的资助改变了指导和培训未来几代研究人员的格局，并为流行性传染病的多学科合作研究提供了最先进的核心资源。在机构一级，COBRE的资助促使人们作出重大承诺，招聘和留住一支新的生产性教师队伍，这种努力将持续到第三阶段。高层管理机构的承诺将确保中心及其核心在COBRE第三阶段之后的可持续性。